Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats

International Immunopharmacology

Volumn 9, Issue 2, 2009, Pages 216-222

  Napimoga, Marcelo H ^a   Benatti, Bruno B ^b   Lima, Flavia O ^c   Alves, Polyanna M ^a   Campos, Alline C ^c   Pena dos Santos, Diego R ^a   Severino, Fernando P ^a   Cunha, Fernando Q ^c   Guimarães, Francisco S ^c  

^a UNIVERSITY OF UBERABA   (Brazil)

^b FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone resorption; Cannabinoid; Inflammation; Periodontal disease

Indexed keywords

CANNABIDIOL; INTERLEUKIN 1BETA; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GINGIVA; MALE; MOLAR TOOTH; MORPHOMETRICS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OSTEOLYSIS; PERIODONTITIS; PRIORITY JOURNAL; RAT; TREATMENT DURATION; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BONE RESORPTION; CANNABIDIOL; CELL MOVEMENT; CYTOKINES; DISEASE MODELS, ANIMAL; MALE; NEUTROPHILS; PERIODONTITIS; PEROXIDASE; RANK LIGAND; RATS; RATS, WISTAR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

EID: 58249144544     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.11.010     Document Type: Article

References (32)

1. Albandar J.M., and Goldstein H. Multi-level statistical models in studies of periodontal diseases. J Periodontol 63 (1992) 690-695
2. Palsson-McDermott E.M., and O'Neill L.A. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113 (2004) 153-162
3. Graves D.T., and Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 74 (2003) 391-401
4. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., and Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20 (1999) 345-357
5. T. Nagasawa, M. Kiji, R. Yashiro, D. Hormdee, H. Lu, M. Kunze, et al. Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease. Periodontol 2000 2007; 43: 65-84.
6. Nakajima Y., Furuichi Y., Biswas K.K., Hashiguchi T., Kawahara K., Yamaji K., et al. Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition. FEBS Lett 580 (2006) 613-619
7. Croxford J.L., and Yamamura T. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?. J Neuroimmunol 166 (2005) 3-18
8. Squitieri F., Cannella M., Sgarbi G., Maglione V., Falleni A., Lenzi P., et al. Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation. Mech Ageing Dev 127 (2006) 217-220
9. Mechoulam R., Gaoni Y., and Hashish I.V. The isolation and structure of cannabinolic cannabidiolic and cannabigerolic acids. Tetrahedron 21 (1965) 1223-1229
10. Devane W.A., Dysarz III F.A., Johnson M.R., Melvin L.S., and Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34 (1988) 605-613
11. Bisogno T., MacCarrone M., De Petrocellis L., Jarrahian A., Finazzi-Agrò A., Hillard C., et al. The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. Eur J Biochem 268 (2001) 1982-1989
12. Watzl B., Scuderi P., and Watson R.R. Influence of marijuana components (THC and CBD) on human mononuclear cell cytokine secretion in vitro. Adv Exp Med Biol 288 (1991) 63-70
13. Sacerdote P., Martucci C., Vaccani A., Bariselli F., Panerai A.E., Colombo A., et al. The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro. J Neuroimmunol 159 (2005) 97-105
14. Malfait A.M., Gallily R., Sumariwalla P.F., Malik A.S., Andreakos E., Mechoulam R., et al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci U S A 97 (2000) 9561-9566
15. Napimoga M.H., Cavada B.S., Alencar N.M., Mota M.L., Bittencourt F.S., Alves-Filho J.C., et al. Lonchocarpus sericeus lectin decreases leukocyte migration and mechanical hypernociception by inhibiting cytokine and chemokines production. Int Immunopharmacol 7 (2007) 824-835
16. Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol 1 (1996) 821-878
17. Teng Y.T. Protective and destructive immunity in the periodontium: part 1-innate and humoral immunity and the periodontium. J Dent Res 85 (2006) 198-208
18. Reddy M.S., Geurs N.C., and Gunsolley J.C. Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review. Ann Periodontol 8 (2003) 12-37
19. Offenbacher S., Heasman P.A., and Collins J.G. Modulation of host PGE2 secretion as a determinant of periodontal disease expression. J Periodontol 64 (1993) 432-444
20. Williams R.C., Jeffcoat M.K., Howell T.H., Reddy M.S., Johnson H.G., Hall C.M., et al. Ibuprofen: an inhibitor of alveolar bone resorption in beagles. J Periodontal Res 23 (1988) 225-229
21. Gurgel B.C., Duarte P.M., Nociti Jr. F.H., Sallum E.A., Casati M.Z., Sallum A.W., et al. Impact of an anti-inflammatory therapy and its withdrawal on the progression of experimental periodontitis in rats. J Periodontol 75 (2004) 1613-1618
22. Cai X., Li C., Du G., and Cao Z. Protective effects of baicalin on ligature-induced periodontitis in rats. J Periodontal Res 43 (2008) 14-21
23. McKallip R.J., Jia W., Schlomer J., Warren J.W., Nagarkatti P.S., and Nagarkatti M. Cannabidiol-induced apoptosis in human leukemia cells: a novel role of cannabidiol in the regulation of p22phox and Nox4 expression. Mol Pharmacol 70 (2006) 897-908
24. Weiss L., Zeira M., Reich S., Slavin S., Raz I., Mechoulam R., et al. Cannabidiol arrests onset of autoimmune diabetes in NOD mice. Neuropharmacology 54 (2008) 244-249
25. Kawai T., Matsuyama T., Hosokawa Y., Makihira S., Seki M., Karimbux N.Y., et al. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol 169 (2006) 987-998
26. Ofek O., Karsak M., Leclerc N., Fogel M., Frenkel B., Wright K., et al. Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci U S A 103 (2006) 696-701
27. Romas E., Gillespie M.T., and Martin T.J. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 30 (2002) 340-346
28. Garlet G.P., Martins Jr. W., Fonseca B.A., Ferreira B.R., and Silva J.S. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol 31 (2004) 671-679
29. Weiss L., Zeira M., Reich S., Har-Noy M., Mechoulam R., Slavin S., et al. Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity 39 (2006) 143-151
30. Kasama T., Miwa Y., Isozaki T., Odai T., Adachi M., and Kunkel S.L. Neutrophil-derived cytokines: potential therapeutic targets in inflammation. Curr Drug Targets Inflamm Allergy 4 (2005) 273-279
31. Palmer G., Gabay C., and Imhof B.A. Leukocyte migration to rheumatoid joints: enzymes take over. Arthritis Rheum 54 (2006) 2707-2710
32. Cattani F., Gallese A., Mosca M., Buanne P., Biordi L., Francavilla S., et al. The role of CXCR2 activity in the contact hypersensitivity response in mice. Eur Cytokine Netw 17 (2006) 42-48